Gabriel Afram

Publications
CV
Public outreach and news

Articles

Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2022;109(6):749-754
Conditioning with melphalan 200 mg/m² and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care
Afram G; Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H
Article: CELL REPORTS MEDICINE. 2022;3(2):100508
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma
Nahi H; Chrobok M; Meinke S; Gran C; Marquardt N; Afram G; Sutlu T; Gilljam M; Stellan B; Wagner AK; Blomberg P; Holmqvist P-H; Walther-Jallow L; Mellstrom K; Liwing J; Gustafsson C; Mansson R; Klimkowska M; Gahrton G; Lund J; Ljungman P; Ljunggren H-G; Alici E
Article: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(8):925-933
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14)
Nahi H; Kashif M; Klimkowska M; Karvouni M; Wallblom A; Gran C; Hauenstein J; Frengen N; Gustafsson C; Afram G; Uttervall K; Lund J; Mansson R; Wagner AK; Alici E
Article: LEUKEMIA & LYMPHOMA. 2021;62(9):2227-2234
Involved free light chain: an early independent predictor of response and progression in multiple myeloma
Gran C; Afram G; Liwing J; Verhoek A; Nahi H
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2021;106(4):546-554
Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups
Afram G; Susek KH; Uttervall K; Wersall JD; Wagner AK; Luong V; Lund J; Gahrton G; Alici E; Nahi H
Article: ANNALS OF HEMATOLOGY. 2021;100(3):779-787
Abatacept as salvage therapy in chronic graft-versus-host disease-a retrospective analysis
Wertheimer T; Dohse M; Afram G; Weber D; Heidenreich M; Holler B; Kattner A-S; Neubauer A; Mielke S; Ljungman P; Holler E; Herr W; Edinger M; Martinez AP; Fante M; Wolff D
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Boberg E; von Bahr L; Afram G; Lindstrom C; Ljungman P; Heldring N; Petzelbauer P; Legert KG; Kadri N; Le Blanc K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(2):196-202
Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment
Afram G; Gran C; Borg Bruchfeld J; Wagner AK; Hussain A; Alici E; Nahi H
Article: CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY. 2019;44(1):84-91
Higher response rates in patients with severe chronic skin graft-versus-host disease treated with extracorporeal photopheresis
Afram G; Watz E; Remberger M; Nygell UA; Sundin M; Hagglund H; Mattsson J; Uhlin M
Article: MEDICAL ONCOLOGY. 2018;35(6):79
Reduced intensity conditioning increases risk of severe cGVHD: identification of risk factors for cGVHD in a multicenter setting
Afram G; Perez-Simon JA; Remberger M; Caballero-Velazquez T; Martino R; Luis Pinana J; Ringden O; Esquirol A; Lopez-Corral L; Garcia I; Lopez-Godino O; Sierra J; Caballero D; Ljungman P; Vazquez L; Hagglund H
Article: HAEMATOLOGICA. 2012;97(8):1187-1195
Evaluation of prognostic factors among patients with chronic graft-versus-host disease
Perez-Simon JA; Afram G; Martino R; Pinana JL; Caballero-Velazquez T; Ringden O; Valcarcel D; Caballero D; Remberger M; de Paz Y; Sierra J; San Miguel J; Hagglund H

All other publications

Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 2023;110(2):224-225
Response to Caravita di Toritto and Rago
Chaireti R; Uttervall K; Luong V; Lund J; Kashif M; Gahrton G; Alici E; Nahi H; Afram G
Letter: INTERNATIONAL JOURNAL OF DERMATOLOGY. 2021;60(7):e271-e273
Pyoderma gangrenosum with plasma cell dyscrasia should be subject for anti-myeloma treatment
Nahi H; Afram G; Brauner H; Talme T; Kuzmina N
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(3):E63-E65
Dynamic follow-up of smoldering multiple myeloma identifies a subset of patients at high risk of progression
Gran C; Luong V; Bruchfeld JB; Liwing J; Afram G; Lund J; Usmani S; Alici E; Nahi H
Thesis / dissertation: 2019
Clinical aspects of chronic graft-versus-host disease
Afram, Gabriel
Letter: BONE MARROW TRANSPLANTATION. 2016;51(11):1518-1521
High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis
Remberger M; Afram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Huddinge, Karolinska Institutet, 2019
University Medical Degree, Karolinska Institutet, 2008

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI